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Summary
Background With increasing age the immune system shows functional decline. In
the skin this is associated with an increased incidence of epidermal malignancies
and infections. Epidermal Langerhans cells (LCs) act as sentinels of the immune
system, recognizing, processing and presenting antigen and inducing T-cell
responses. Previous investigations have demonstrated a reduction in the number
of epidermal LCs in elderly subjects. Moreover, the ability of LCs to migrate in
response to tumour necrosis factor (TNF)-a, but not interleukin (IL)-1b,i s
signiﬁcantly impaired in the elderly.
Objectives To characterize further the changes in LC function that are associated
with increasing chronological age, we have evaluated age-related changes in the
response of monocyte-derived LCs (mLCs) to IL-1b and TNF-a.
Methods The phenotype and function of mLCs were compared in six young
(£ 30 years) and six aged (‡ 70 years) healthy individuals using a combination of
ﬂow cytometry, cytokine and chemokine array, and a Transwell migration assay.
Results Monocytes from aged individuals were able to differentiate into LCs. There
were no signiﬁcant differences in expression of activation markers, or in baseline
or inducible cytokine secretion, by mLCs derived from aged or young subjects.
Furthermore, migration in response to a chemokine ligand, CCL19, was equiva-
lent in both age groups.
Conclusions These data demonstrate that changes in LC function in the elderly are
not associated with changes in systemic dendritic cell phenotype and function.
Conditioning of LCs in situ by the epidermal microenvironment is likely to be
more important.
Ageing of the skin immune system is associated with an in-
creased incidence of epidermal malignancies and infections, a
decreased incidence of contact allergy, and the development
of autoimmunity. Epidermal Langerhans cells (LCs) act as
sentinels of the adaptive immune system, and are adept at
processing antigen. Following an external challenge a propor-
tion of epidermal LCs is mobilized and migrates to local
skin-draining lymph nodes. While in transit they acquire
immunostimulatory properties to facilitate antigen presenta-
tion to T cells.
1 In order to migrate LCs require independent
signals from both interleukin (IL)-1b and tumour necrosis
factor (TNF)-a. Activated LCs release IL-1b that provides one
signal for migration and also triggers production of TNF-a
by adjacent keratinocytes. The TNF-a then acts upon LCs
in a paracrine fashion to provide a second stimulus for
migration.
2 Previous investigations have demonstrated a
reduction in the number of epidermal LCs in elderly
subjects.
3 Moreover, the ability of LCs to migrate in response
to TNF-a, but not IL-1b, is impaired in the elderly, the sug-
gestion being that in elderly individuals endogenous IL-1b
signalling is perturbed.
4,5
During inﬂammation and⁄or injury LCs appear to be
replaced by blood-derived precursors, whereas in the steady
state they are replaced by local precursors.
6,7 In vitro CD14+
monocytes cultured in the presence of transforming growth
factor (TGF)-b, granulocyte⁄macrophage colony-stimulating
factor (GM-CSF) and IL-4 develop into dendritic cells (DCs)
with an LC-like phenotype. These monocyte-derived LCs
(mLCs) express CD1a, E-cadherin and langerin,
8 and stimula-
tion with IL-1b and TNF-a can trigger upregulation of mark-
ers of activation.
9 With the objective of characterizing further
the changes in LC function that are associated with increasing
chronological age, we have here evaluated age-related changes
in the response of mLCs to IL-1b and TNF-a.
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The study was approved by the local Research Ethics Commit-
tee. All participants were required to give written informed
consent.
Culture of Langerhans cells from monocytes
CD14+ monocytes were isolated from peripheral blood mono-
nuclear cells of healthy young (£ 30 years) and healthy aged
(‡ 70 years) volunteers using negative selection with magnetic
(a)
(b)
(c)
(d)
Fig 1. Expression of CD1a, HLA-DR, CD86 and CD54 (a–d, respectively) in monocyte-derived Langerhans cells from young and old subjects
(n = 6) as measured by mean ﬂuorescence intensity (MFI) of cells cultured with media alone (negative control) and poststimulation with
100 ng mL
)1 of either interleukin (IL)-1b or tumour necrosis factor (TNF)-a. The effect of age and stimulation upon expression of markers of
interest was measured using two-way analysis of variance and Bonferroni post test; data are presented as mean ± SEM. *P<0Æ05, **P<0Æ01,
***P<0Æ001.
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Bisley, U.K.). Cells were cultured for 5 days in medium con-
taining IL-4, TGF-b (both at 10 ng mL
)1) and GM-CSF (at
250 ng mL
)1) (all R&D Systems, Abingdon, U.K.). On day 6,
cells were stimulated with 100 ng mL
)1 of IL-1b or TNF-a
(both R&D Systems) and then cultured for a further 24 h
prior to analysis.
Analysis of monocyte-derived Langerhans cells using
ﬂow cytometry
mLCs were stained with HLA-DR (Dako, Stockport, U.K.;
clone DK22), CD1a (Dako; clone NA 1⁄34), CD54 (BD Bio-
science, Oxford, U.K.; clone HA58) and CD86 [BD Bioscience;
clone 2331 (FUN-1)] or isotype control antibodies followed
by ﬂuorescein isothiocyanate-labelled polyclonal goat anti-
mouse immunoglobulin (Dako). Cells were analysed by
ﬂow cytometry using FACSCalibur and CellQuest Pro software
(Becton-Dickinson, Franklin Lakes, NJ, U.S.A.).
Cytokine array
Concentrations of IL-1b, TNF-a, IL-10, IL-1Ra, CCL3 and
CCL4 were measured in culture supernatants using a Bio-Plex
cytokine and chemokine array according to the manufacturer’s
instructions (Bio-Rad Laboratories, Hercules, CA, U.S.A.) and
analysed using a Luminex system (Luminex 100; MiraiBio Hit-
achi Genetic Systems, South San Francisco, CA, U.S.A.).
Transwell migration assay
Migration of mLCs was measured using a Transwell assay.
Medium containing either vehicle or 200 ng mL
)1 of CCL19
(R&D Systems) was added to the lower chamber and 2 · 10
5
of either unstimulated or stimulated (with 100 ng mL
)1 of
IL-1b) mLCs were added to the upper chamber. The cells
were incubated for 3 h at 37  C and ﬂuid was aspirated from
the lower chamber and cell counts performed in triplicate
using a Casy TT counter (Roche Innovatis, Basel, Switzerland).
Results
Comparison of monocyte-derived Langerhans cells from
young and aged individuals using ﬂow cytometry
Peripheral blood monocytes were isolated from the blood of
six young (age range 20–30 years, mean 25Æ5) and six old
healthy volunteers (age range 70–78 years, mean 74Æ2).
Monocyte yield was equivalent between the age groups.
The response of mLCs to stimulation with IL-1b and TNF-a
was determined ﬁrstly by examining the relative levels of
expression of markers of LC maturation and activation,
recorded as mean ﬂuorescence intensity using analytical ﬂow
cytometry. Lipopolysaccharide (LPS) was used as a positive
control (data not shown). As expected, a high percentage of
both unstimulated and stimulated mLCs expressed CD1a in
both age groups Stimulation did not signiﬁcantly affect the
level of expression of CD1a in either age group (Fig. 1a).
Most mLCs were HLA-DR+. The level of expression increased
signiﬁcantly in both age groups following stimulation with
IL-1b, but not TNF-a (Fig. 1b). Only a relatively small
percentage of mLCs was CD86+; however, stimulation with
IL-1b led to increased levels of CD86 expression in both
groups (Fig. 1c). Most mLCs were CD54+ and stimulation
with both cytokines upregulated expression (Fig. 1d). There
were no signiﬁcant differences between the young and old
groups in terms of level of expression of markers at baseline
or poststimulation.
Quantiﬁcation of cytokines and chemokines secreted by
monocyte-derived Langerhans cells from young and aged
individuals
Secretion of cytokines involved in LC maturation and migra-
tion was measured in culture supernatants from unstimulated
and stimulated mLCs using cytokine bead array (Fig. 2). There
were no differences between the young and old groups. The
levels of IL-1b were uniformly low and did not increase sig-
niﬁcantly following stimulation with TNF-a. However, stimu-
lation with IL-1b led to signiﬁcant increases in the secreted
levels of TNF-a, IL-10, CCL3 and CCL4.
Migration of monocyte-derived Langerhans cells from
young and aged individuals in response to a chemokine
ligand
A Transwell migration assay was used to determine the effect
of IL-1b stimulation on the migratory response of mLCs
derived from young and old individuals to the chemokine
ligand CCL19 (Fig. 3). IL-1b stimulation induced migration in
response to CCL19 in mLCs from both age groups. There were
no signiﬁcant differences between the age groups.
Discussion
The ability of peripheral blood monocytes to differentiate into
LCs was not impaired in aged subjects. Consistent with previ-
ous reports, a high proportion of the cells expressed CD1a,
HLA-DR and CD54, with an upregulation of HLA-DR and
CD86 expression observed following stimulation.
8–11 Pheno-
typically there were no differences in mLCs from young and
old individuals. This corresponds to results of earlier studies
that have found that the phenotype of monocyte-derived
DCs (mDCs) is not affected by the ageing process.
12,13
Although secretion of cytokines by mLCs and mDCs is not
directly comparable,
9 the evidence for age-associated change
is variable.
12–14 In this study secretion of chemokines and
cytokines involved in LC migration was not impaired; further-
more, there was no increase in secretion of the inhibitory
cytokines, IL-1Ra and IL-10, which could have accounted for
a reduction in LC migration as seen in aged individuals. Inter-
estingly, the migratory response of LPS-stimulated mDCs from
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186 Monocyte-derived Langerhans cells are not affected by ageing, S. Ogden et al.Fig 2. Levels of secreted cytokines and chemokines involved in Langerhans cell (LC) maturation and ⁄or migration were measured in culture
supernatants of unstimulated (media) and stimulated [100 ng mL
)1 interleukin (IL)-1b or tumour necrosis factor (TNF)-a] monocyte-derived LCs
derived from young and old individuals (n=6) using cytokine bead array. Analysis of the effects of stimulation and age group was performed
using two-way analysis of variance and Bonferroni post test; data are presented as mean ± SEM. *P<0Æ05, **P<0Æ01, ***P<0Æ001.
Fig 3. Migratory response of unstimulated (media) and stimulated [100 ng mL
)1 interleukin (IL)-1b] monocyte-derived Langerhans cells to
CCL19 was measured using a Transwell migration assay (n=5). The percentage of cells that migrated was calculated and analysis of the effects of
IL-1b stimulation and age group was performed using two-way analysis of variance and Bonferroni post test; data are presented as mean ± SEM.
**P<0Æ01, ***P<0Æ001.
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et al.,
12 yet in the current study IL-1b-stimulated mLCs from
aged individuals migrated normally in response to CCL19.
This may be because of inherent differences in the cell types,
as in our study stimulation with LPS did not cause increased
migration to CCL19 in either age group (data not shown).
Taken together, these data demonstrate that changes in LC
function in the elderly are not associated with changes in
systemic DC phenotype and function. Thus, conditioning of
LCs in situ by the epidermal environment is likely to be more
important.
What’s already known about this topic?
• Chronological ageing is associated with impairment of
the cutaneous immune response.
• There is an age-associated reduction in Langerhans cell
number and function.
• During inﬂammation⁄injury Langerhans cells are
thought to be replaced by circulating monocyte precur-
sors.
What does this study add?
• The phenotype and function of monocyte-derived
Langerhans cells are not altered by the ageing process.
• Changes in the epidermal environment are likely to be
more important.
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